Fig. 4From: Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective studyKaplan-Meier survival analyses for assessment of the effect of C1orf63 expression in three different subtypes of breast cancer (log-rank test). Survival analyses of C1orf63 expression separately in luminal breast cancer(a), HER-2 enriched breast cancer (b), and triple negative breast cancer (c)Back to article page